Updates are available Correction dated 2026-04-17
Click to view Correction: https://doi.org/10.1007/s40121-026-01347-y
-
Authors
Srivastava, Prakhar
Singleton, Elizabeth
Morrisette, Taylor
Berti, Andrew David
Ventresca, Remo Lorenzo
Brassell, Emily
Benin, Lyuba
Kebriaei, Razieh https://orcid.org/0000-0003-4019-2679
- License Information
-
More Information
Article History
Received: 18 September 2025
Accepted: 3 December 2025
First Online: 20 December 2025
Change Date: 18 April 2026
Change Type: Update
Change Details: The original online version of this article was revised: “the author’s name Remo Lorenzo Ventresca was incorrectly written as Remi Lorenzo Ventresca.”
Change Date: 17 April 2026
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40121-026-01347-y
Declarations
:
: Taylor Morrisette is currently receiving grant funding through Stellus Rx and AbbVie Inc.; has participated in scientific advisory boards for AbbVie Inc. and Basilea Pharmaceutica; has provided expert witness testimony to Copeland, Stair Valz & Lovell, and Huff, Powell & Bailey; and has received honoraria from Infectious Diseases Special Edition and Managed Healthcare Executive. Razieh Kebriaei is supported by National Institutes of Health (NIH) grant no. R03AI183164-01. All other authors (Prakhar Srivastava, Elizabeth Singleton, Andrew David Berti, Remo Lorenzo Ventresca, Emily Brassell, and Lyuba Benin) have no conflict of interest.
: This article is a review of previously published studies and does not involve any new experiments on humans or animals. Therefore, ethical approval and informed consent were not required.
